Back to Search
Start Over
Oligometastatic prostate cancer: Metastases-directed therapy?
- Source :
- Arab Journal of Urology
- Publication Year :
- 2016
- Publisher :
- Elsevier BV, 2016.
-
Abstract
- Since the introduction of anatomical and functional imaging with multiparametric magnetic resonance imaging and choline or prostate-specific membrane antigen positron emission tomography–computed tomography, we are able to diagnose a previously unknown disease, the oligometastatic prostate cancer after local therapy. Reports on surgical and radiation treatment for low-volume metastatic recurrence have shown promising results, with definitive cure in few but a relevant delay of androgen-deprivation therapy with both treatment methods. Obviously, these results need to be validated with prospective randomised data.
- Subjects :
- Oncology
medicine.medical_specialty
Stereotactic body radiotherapy
Urology
030232 urology & nephrology
ADT, androgen-deprivation therapy
Disease
CPFS, clinical progression-free survival
Lymph node dissection
LND, lymph node dissection
PET, positron emission tomography
Androgen deprivation therapy
03 medical and health sciences
Prostate cancer
0302 clinical medicine
Internal medicine
Medicine
Positron emission
Multiparametric Magnetic Resonance Imaging
Membrane antigen
medicine.diagnostic_test
business.industry
BRFS, biochemical recurrence-free survival
(SB)RT, (stereotactic body) radiotherapy
Mini-Review
medicine.disease
Oligometastatic prostate cancer
Functional imaging
Positron emission tomography
030220 oncology & carcinogenesis
CSS, cancer-specific survival
business
Subjects
Details
- ISSN :
- 2090598X
- Volume :
- 14
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Arab Journal of Urology
- Accession number :
- edsair.doi.dedup.....5fe4c8b5826bdf45eefa6241c02c7d36
- Full Text :
- https://doi.org/10.1016/j.aju.2016.06.004